Newly Approved Spinal Muscular Atrophy Gene Therapy, Zolgensma ® ,...

AskBio continues to lead the path for gene therapy development and cost-effective manufacturing methods based on the contributions of its co-founder, Dr. Jude Samulski.(PRWeb May 30, 2019)Read the full story at https://www.prweb.com/releases/newly_approved_spinal_muscular_atrophy_gene_therapy_zolgensma_validates_askbio_gene_therapy_platform/prweb16344912.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news